Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Walgreens Boots Alliance Inc

Will Walgreens (WBA) Earnings Present Prime Investment Opportunities?

Over the recent months, pharmaceutical retailer Walgreens Boots Alliance (WBA) has witnessed a major drop in its shares as a result of announcing dividend cuts and losing its spot among the top 30 blue chip companies. However, with the company’s fiscal second results on the horizon, should investors be keen…

StockNews.com · Mar 27, 2024

Will These 3 Medical Stocks Make Gains in 2024?

Technological advances, rising healthcare costs, and the robust demand for medicines and healthcare services due to an aging population and the rise in chronic diseases are boosting the prospects of the medical sector. So, should you invest in Walgreens Boots Alliance (WBA), Tenet Healthcare (THC) and LifeVantage (LFVN) for gains?…

StockNews.com · Jan 17, 2024

Walgreens Boots Alliance (WBA) Earnings Alert: Opportunities and Challenges

Walgreens Boots Alliance (WBA) is currently focusing on enhancing fiscal efficiency through strategic initiatives. However, given its mixed financials, does the upcoming fiscal 2024 first-quarter earnings signal an opportune entry point or potential challenges for investors? Read more to find out.

StockNews.com · Jan 2, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Watch: Is Walgreens Boots Alliance (WBA) a Solid Buy Before Earnings?

Retail drugstore chain Walgreens Boots Alliance (WBA) achieved adjusted EPS growth on solid sales increase in the third quarter of fiscal 2023. However, the company lowered its full-year earnings guidance to reflect challenging consumer and macro conditions and lower COVID-19 demand. So, let’s determine if WBA is a buy before…

StockNews.com · Oct 9, 2023

Walgreens Boots Alliance (WBA), CVS Health (CVS), and Rite Aid (RAD): Buy, Hold or Sell?

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

StockNews.com · Aug 17, 2023

Which of These 3 Medical Stocks Has the Better Growth Opportunities?

The medical sector is expected to grow amid steady demand and technological advancements. So, let's analyze which of these stocks, CVS Health (CVS), Walgreens Boots Alliance (WBA), and TRxADE HEALTH (MEDS), has the better growth opportunities.

StockNews.com · Aug 11, 2023

Is Walgreens Boots Alliance (WBA) a Buy, Sell, or Hold This Month?

Drug store operator Walgreens Boots Alliance (WBA) expects to face a drop in its sales due to inflationary pressures. However, given its efforts to streamline operations, should investors buy, sell, or hold the stock this month? Let’s look at its key financial metrics trends to gauge its performance….

StockNews.com · Jul 7, 2023

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Stocks to Watch This Week

Amid rising risks of a recession later this year and current market volatility, dividend stocks could ensure a steady income stream. Therefore, investors could consider adding fundamentally strong dividend stocks 3M Company (MMM), Dow (DOW), and Walgreens Boots Alliance (WBA) to their watchlist. Keep reading.

StockNews.com · Jun 1, 2023

Build Up Your Portfolio’s Defense With These 3 Highest Yielding Dividend Aristocrats!

In Focus: 3 High-Yielding Dividend Aristocrats To Check Out Today

Barchart · May 4, 2023

Build Up Your Portfolio’s Defense With These Dividend Aristocrats!

In Focus: 3 High-Yielding Dividend Aristocrats To Check Out Today

Barchart · May 4, 2023

Just In: WBA Named the Top Dividend Stock With Insider Buying. Is It a Buy?

Walgreens Boots Alliance (WBA) is a popular dividend aristocrat that witnessed insider buying last month. Given the possibility of a recession this year, will it be wise to buy the stock now? Read on to learn our view….

StockNews.com · Apr 20, 2023

A Look Into Walgreens Boots Alliance's Debt

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) fell by 3.47% in the past three months. Before having a look at the importance of debt, let's look at how much debt Walgreens Boots Alliance has.

Benzinga · Nov 7, 2022

CVS, Walmart, Walgreens reach tentative $12 billion opioid pact

CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. have tentatively agreed to pay more than $12 billion to resolve thousands of state and local government lawsuits accusing the chains of mishandling opioid painkillers, according to people familiar with the matter.

Tribune News Service · Nov 2, 2022

5 Blue Chip Stocks to Help You Beat the Market Slump

Rising concerns over stubbornly-high inflation and the Fed’s commitment to bring it down to its desired level have kept equities under pressure lately. Amid increasing recessionary concerns, investing in blue-chip stocks such as Procter & Gamble (PG), AbbVie (ABBV), Pfizer (PFE), Dow (DOW), and Walgreens Boots Alliance (WBA) could help…

StockNews.com · Sep 23, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Jul 14, 2022

Walgreen Halts Sale of Boots Chain. Does This Mean the Stock Is No Longer a Good Buy?

Walgreen Boots Alliance’s (WBA) failure to secure the right valuation for its pharmacy chain Boots and consumer goods company No7 Beauty for divesting them made investors concerned. With the company now focusing on accelerating the growth and profitability of these two units, will it be wise to buy the stock…

Benzinga · Jul 5, 2022

RBC Says This Pharmacy Chain Has Health Investments On Track Despite Abandoning Divestiture

RBC Capital Markets lowered the price target on Walgreens Boots Alliance Inc (NASDAQ:WBA) to $42 (10% upside) from $46 and maintained the Sector Perform rating. The analysts say that WBA posted solid fiscal 3Q22 results slightly ahead of their estimates and consensus on steady execution in the U.S. against a difficult comp and continued…

StockNews.com · Jun 30, 2022

Buy-Rated Walgreens Could Be a Recession Winner

With analysts forecasting a recession later this year, investors should consider investing in almost recession-proof stocks. To that end, it could be wise to consider investing in drug store operator Walgreens Boots Alliance (WBA) as the demand for drugs remains stable irrespective of the economic conditions. With robust financials and…

Benzinga · Jun 30, 2022

Walgreens Posts Fall In Q3 Profit On Opioid Settlement, Lower Pharmacy Sales

Walgreens Boots Alliance Inc's (NASDAQ:WBA) Q3 FY22 sales decreased 4.2% Y/Y to $32.6 billion, down 2.8% on a constant currency basis, beating the consensus of $32.06 billion. Adjusted EPS reached $0.96, beating the consensus of $0.92, down 28.9% on a constant currency basis against 93.6% growth a year ago that reflected peak…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Jun 28, 2022

Walgreens Retains Boots Business Ownership Amid Market Instability

Walgreens Boots Alliance Inc (NASDAQ:WBA) has decided to retain its Boots and No7 Beauty Company businesses under its existing ownership. The decision marks the conclusion of the review that began in January. The discussions Walgreens had with potential buyers did not yield expected results as the recent market instability severely impacted the financial availability…

Benzinga · Jun 28, 2022

Effect Of Roe Vs. Wade Ruling - Pharmacies Ration Contraceptive Pills

Major pharmacies like CVS Health Corp (NYSE:CVS), Walmart Inc (NYSE:WMT), and Rite Aid Corporation (NYSE:RAD) have put a limit on purchases or deliveries of Plan B and other emergency contraceptive pills, writes Wall Street Journal. The move comes as demand for contraceptive pills spiked following the Supreme Court ruling overturning a constitutional right to abortion. These were in…

Benzinga · Jun 16, 2022

Walgreens Launches Clinical Trial Business

Walgreens Boots Alliance Inc (NASDAQ:WBA) has launched its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research. Walgreens will combine the flexible clinical trial model with its vast data on patient insights, partner-enabled health and technology capabilities, and in-person and virtual care options. The…

Benzinga · Jun 9, 2022

India's Apollo Global, Reliance Make a Binding Offer For UK's Boots: Bloomberg

Apollo Global Management Inc. (NYSE:APO) and Ambani's Reliance Industries Ltd. led consortium have made a binding offer for Walgreens Boots Alliance Inc.'s (NASDAQ:WBA) international arm, reported Bloomberg, citing people familiar with the matter. The source stated that the proposal values Boots at more than £5 billion ($6.3 billion). Walgreens is seeking a valuation of around £7…

Benzinga · May 12, 2022

What's Going On With AmerisourceBergen Shares Today

Walgreens Boots Alliance Inc (NASDAQ:WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE:ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%. Chief Operating Officer, International of Walgreens Boots Alliance, Ornella Barra, will continue to serve on AmerisourceBergen's Board of Directors. WBA…

Benzinga · May 11, 2022

Ohio Lawyer Says Pharmacy Distributors To Pay $878M For Opioid Epidemic

A lawyer for two Ohio counties said that CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance Inc (NASDAQ:WBA), and Walmart Inc (NYSE:WMT) should fund an $878 million plan addressing the opioid crisis, writes Reuters. In November, a federal jury decided that the companies created a public nuisance by flooding Ohio's Lake and Trumbull counties with addictive prescription pain…

Benzinga · May 10, 2022

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

1 2

Coverage From

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.